Skip to main content

McDade Mark

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists McDade Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TRML Tourmaline Bio, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2024 (view filing)Jan 292 daysMcDade MarkDirectorPPurchase+100.0K$32.50+$3.25M+28.7%448.4K after

JSPR Jasper Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 11, 2023 (view filing)7:55 PM ETJan 2774 daysLateMcDade Mark and 3 others10% OwnerPPurchaseVoting Common Stock+2.67M$1.50+$4.00M+45.6%8.52M after

ICVX Icosavax, Inc.

Other: See Remarks2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 5, 2022 (view filing)Apr 14 daysMcDade MarkDirectorPPurchase+42.2K$7.10+$299.8K+526.6%50.2K after
Aug 2, 2021 (view filing)9:27 PM ETAug 2Same dayMcDade Mark and 2 othersOther: Former 10% OwnerPPurchase+221.4K$15.00+$3.32M+6.7%3.52M after3 lots